ALCON RESEARCH

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Three Month Efficacy/Safety Study With a 3-Month Safety Extension of Brinzolamide 1%/Brimonidine 0.2% vs. Brinzolamide 1% or Brimonidine 0.2%

Phase 3

Completed

Conditions: Open-Angle Glaucoma
Ocular Hypertension

Interventions: Drug: Brinzolamide 1%/brimonidine tartrate 0.2% ophthalmic suspension
Drug: Brinzolamide ophthalmic suspension, 1%
Drug: Brimonidine tartrate ophthalmic solution, 0.2%

First Posted Date: 2011-02-17

Last Posted Date: 2013-07-04

Lead Sponsor: Alcon Research

Target Recruit Count: 1062

Registration Number: NCT01297920

Efficacy and Safety Study of Brinzolamide 1%/Brimonidine 0.2% vs. Brinzolamide 1% and Brimonidine 0.2%

Phase 3

Completed

Conditions: Open-Angle Glaucoma
Ocular Hypertension

Interventions: Drug: Brinzolamide 1%/brimonidine tartrate 0.2% ophthalmic suspension
Drug: Brinzolamide ophthalmic suspension, 1%
Drug: Brimonidine tartrate ophthalmic solution, 0.2%

First Posted Date: 2011-02-16

Last Posted Date: 2013-05-21

Lead Sponsor: Alcon Research

Target Recruit Count: 1001

Registration Number: NCT01297517

Patient Perception Study for AL-4943A

Phase 4

Completed

Conditions: Allergic Conjunctivitis

Interventions: Drug: AL-4943A

First Posted Date: 2011-02-14

Last Posted Date: 2016-12-16

Lead Sponsor: Alcon Research

Target Recruit Count: 47

Registration Number: NCT01294969

Locations: 🇰🇷
Alcon Korea Ltd., Seoul, Korea, Republic of

A Clinical Evaluation of an Investigational Lubricant Eye Gel (FID 115958D)

Not Applicable

Completed

Conditions: Dry Eye

Interventions: Other: Lubricant Eye Drop
Other: Refresh Liquigel

First Posted Date: 2011-02-14

Last Posted Date: 2016-11-18

Lead Sponsor: Alcon Research

Target Recruit Count: 147

Registration Number: NCT01294956

Visual Outcomes After Cataract Surgery: Multifocal AcrySof® IQ ReSTOR® Intraocular Lenses Versus Monofocal Intraocular Lenses

Not Applicable

Completed

Conditions: Cataract

Interventions: Device: AcrySof® IQ ReSTOR® +3.0 D Multifocal IOL
Device: Monofocal IOL
Device: AcrySof® IQ ReSTOR® +3.0 D Multifocal Toric IOL

First Posted Date: 2011-02-04

Last Posted Date: 2018-07-02

Lead Sponsor: Alcon Research

Target Recruit Count: 208

Registration Number: NCT01290068

Assessment of Alcon's Ocular Image Quantification System

Phase 4

Completed

Conditions: Allergic Conjunctivitis

Interventions: Drug: Olopatadine hydrochloride, 0.1% ophthalmic solution (Patanol)
Other: Dextran 70 0.1%, hydroxypropyl methylcellulose 0.3% (Tears Naturale II)

First Posted Date: 2011-01-24

Last Posted Date: 2012-12-18

Lead Sponsor: Alcon Research

Target Recruit Count: 13

Registration Number: NCT01282138

Locations: 🇺🇸
Contact Alcon Call Center for Trial Locations, Fort Worth, Texas, United States

Evaluation of Anti-Inflammatory Treatment in Dry Eye Patients

Phase 2

Completed

Conditions: Dry Eye Disease

Interventions: Drug: Difluprednate 0.05% ophthalmic emulsion
Other: Difluprednate vehicle

First Posted Date: 2011-01-13

Last Posted Date: 2013-03-11

Lead Sponsor: Alcon Research

Target Recruit Count: 722

Registration Number: NCT01276223

Locations: 🇺🇸
Contact Alcon Call Center at 1-888-451-3937 for Trial Locations, Fort Worth, Texas, United States

A Study of Patient Perception and Quality of Life Associated With the Use of Olopatadine 0.2% in Subjects With Allergic Conjunctivitis

Phase 4

Completed

Conditions: Allergic Conjunctivitis

Interventions: Drug: Olopatadine Hydrochloride Ophthalmic Solution, 0.2%

First Posted Date: 2011-01-07

Last Posted Date: 2012-09-18

Lead Sponsor: Alcon Research

Target Recruit Count: 300

Registration Number: NCT01272089

Safety and Efficacy of Adding AZARGA® Adjunctive to Prostaglandin Therapy

Phase 4

Completed

Conditions: Glaucoma
Ocular Hypertension

Interventions: Drug: Brinzolamide 1% / timolol 0.5% Fixed Combination
Drug: Habitual prostaglandin monotherapy

First Posted Date: 2010-12-20

Last Posted Date: 2014-05-20

Lead Sponsor: Alcon Research

Target Recruit Count: 47

Registration Number: NCT01263444

A Comparison of Visual Function After Bilateral Implantation of Presbyopia-Correcting Intraocular Lenses (IOLs)

Not Applicable

Completed

Conditions: Cataract

Interventions: Device: Acri.LISA® 366D IOL
Device: AcrySof® IQ ReSTOR® +3.0 D Multifocal IOL Model SN6AD1
Device: Acri.LISA® 466TD Toric IOL
Device: AcrySof® IQ ReSTOR® +3.0 D Multifocal Toric IOL Model SND1TT

First Posted Date: 2010-12-09

Last Posted Date: 2018-07-02

Lead Sponsor: Alcon Research

Target Recruit Count: 31

Registration Number: NCT01257217

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy